News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,540 Results
Type
Article (13243)
Company Profile (24)
Press Release (167272)
Multimedia
Podcasts (19)
Webinars (5)
Section
Business (48582)
Career Advice (614)
Deals (9100)
Drug Delivery (34)
Drug Development (28054)
Employer Resources (69)
FDA (4734)
Job Trends (3874)
News (91107)
Policy (7881)
Tag
2027 Pharm Country Standard (1)
Academia (1074)
Academic (1)
Accelerated approval (7)
Adcomms (9)
Allergies (53)
Alliances (13683)
ALS (60)
Alzheimer's disease (506)
Antibody-drug conjugate (ADC) (57)
Approvals (4865)
Artificial intelligence (115)
Autoimmune disease (31)
Automation (8)
Bankruptcy (70)
Best Places to Work (3199)
BIOSECURE Act (6)
Biosimilars (74)
Biotechnology (11)
Bladder cancer (45)
Brain cancer (16)
Breast cancer (186)
Cancer (1223)
Cardiovascular disease (151)
Career advice (528)
Career pathing (14)
CAR-T (76)
CDC (21)
Celiac Disease (1)
Cell therapy (184)
Cervical cancer (11)
Clinical research (24938)
Collaboration (367)
Company closure (1)
Compensation (41)
Complete response letters (9)
COVID-19 (1130)
CRISPR (21)
C-suite (189)
Cystic fibrosis (28)
Data (2031)
Denatured (10)
Depression (39)
Diabetes (183)
Diagnostics (1776)
Digital health (9)
Diversity (8)
Diversity, equity & inclusion (29)
Drug discovery (56)
Drug pricing (59)
Drug shortages (17)
Duchenne muscular dystrophy (71)
Earnings (14981)
Editorial (25)
Employer branding (5)
Employer resources (64)
Events (21793)
Executive appointments (245)
FDA (5594)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (381)
Gene editing (40)
Generative AI (12)
Gene therapy (163)
GLP-1 (356)
Government (1258)
Grass and pollen (3)
Guidances (107)
Healthcare (5382)
HIV (30)
Huntington's disease (12)
IgA nephropathy (21)
Immunology and inflammation (63)
Immuno-oncology (15)
Indications (26)
Infectious disease (1216)
Inflammatory bowel disease (66)
Inflation Reduction Act (6)
Influenza (35)
Intellectual property (28)
Interviews (105)
IPO (3448)
IRA (22)
Job creations (773)
Job search strategy (451)
JPM (16)
Kidney cancer (4)
Labor market (21)
Layoffs (104)
Leadership (17)
Legal (1534)
Liver cancer (27)
Longevity (2)
Lung cancer (132)
Lymphoma (108)
Machine learning (7)
Management (22)
Manufacturing (176)
MASH (67)
Medical device (3237)
Medtech (3254)
Mergers & acquisitions (5938)
Metabolic disorders (421)
Multiple sclerosis (74)
NASH (15)
Neurodegenerative disease (78)
Neuropsychiatric disorders (16)
Neuroscience (886)
NextGen: Class of 2026 (1995)
Non-profit (1640)
Now hiring (5)
Obesity (171)
Opinion (60)
Ovarian cancer (43)
Pain (52)
Pancreatic cancer (45)
Parkinson's disease (94)
Partnered (13)
Patents (41)
Patient recruitment (112)
Peanut (19)
People (17675)
Pharmaceutical (9)
Pharmacy benefit managers (11)
Phase 1 (5508)
Phase 2 (10735)
Phase 3 (10190)
Pipeline (1309)
Policy (104)
Postmarket research (1147)
Preclinical (2006)
Press Release (29)
Prostate cancer (82)
Psychedelics (16)
Radiopharmaceuticals (66)
Rare diseases (231)
Real estate (1389)
Recruiting (23)
Regulatory (6356)
Reports (14)
Research institute (913)
Resumes & cover letters (83)
Rett syndrome (2)
RNA editing (1)
RSV (28)
Schizophrenia (42)
Series A (78)
Series B (54)
Service/supplier (2)
Sickle cell disease (25)
Special edition (3)
Spinal muscular atrophy (67)
Sponsored (10)
Startups (1185)
Stomach cancer (5)
Supply chain (23)
Tariffs (17)
The Weekly (9)
Vaccines (382)
Venture capital (22)
Weight loss (126)
Women's health (22)
Worklife (8)
Date
Last 7 days (142)
Last 30 days (446)
Last 365 days (7085)
2026 (577)
2025 (7332)
2024 (8407)
2023 (9580)
2022 (12871)
2021 (14465)
2020 (14040)
2019 (13513)
2018 (10430)
2017 (9479)
2016 (9131)
2015 (10801)
2014 (7356)
2013 (5763)
2012 (6225)
2011 (6605)
2010 (5694)
Location
Africa (262)
Alabama (9)
Alaska (4)
Arizona (63)
Arkansas (2)
Asia (12963)
Australia (2477)
California (2232)
Canada (587)
China (354)
Colorado (74)
Connecticut (78)
Delaware (100)
Europe (34451)
Florida (346)
Georgia (111)
Idaho (15)
Illinois (241)
India (20)
Indiana (147)
Iowa (3)
Japan (176)
Kansas (39)
Kentucky (14)
Louisiana (10)
Maine (12)
Maryland (338)
Massachusetts (1501)
Michigan (52)
Minnesota (142)
Missouri (32)
Montana (6)
Nebraska (7)
Nevada (32)
New Hampshire (11)
New Jersey (774)
New Mexico (7)
New York (753)
North Carolina (286)
Northern California (1066)
Ohio (73)
Oklahoma (3)
Oregon (5)
Pennsylvania (478)
Puerto Rico (4)
Rhode Island (4)
South America (376)
South Carolina (10)
Southern California (897)
Tennessee (32)
Texas (293)
United States (8414)
Utah (56)
Virginia (50)
Washington D.C. (8)
Washington State (218)
Wisconsin (21)
Wyoming (2)
180,540 Results for "emmes group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma
January 16, 2025
·
3 min read
Drug Development
ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine
ILiAD Biotechnologies, LLC today announced the selection of Emmes Group, a global contract research and technology organization, to conduct upcoming Phase III studies of its lead pertussis vaccine candidate, BPZE1. ILiAD and Emmes Group are currently working to finalize the definitive agreement.
June 24, 2024
·
4 min read
Press Releases
Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco
December 24, 2025
·
4 min read
Press Releases
Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science
February 5, 2026
·
2 min read
Press Releases
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
February 3, 2026
·
7 min read
Press Releases
Pharming Group reports preliminary 2025 revenues and announces Investor Day
January 8, 2026
·
5 min read
Press Releases
Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology
January 12, 2026
·
3 min read
Press Releases
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
January 8, 2026
·
4 min read
Press Releases
SSI Diagnostica Group strengthens life science portfolio for vaccine development and quality control with acquisition of US-based multiplexing company
February 4, 2026
·
1 min read
Mergers & acquisitions
Big Pharma Dealmakers Joined by Spunky Group of Biotech Buyers in Q4
While Novartis secured the biggest deal of the fourth quarter, a handful of riveting tales emerged from the bottom of the M&A list, including a zombie buyout and a bidding war. And no, we’re not talking about Metsera.
January 2, 2026
·
2 min read
·
Annalee Armstrong
1 of 18,054
Next
